期刊
CANCER CELL
卷 1, 期 2, 页码 181-191出版社
CELL PRESS
DOI: 10.1016/S1535-6108(02)00033-8
关键词
-
资金
- NATIONAL CANCER INSTITUTE [R01CA081008, T32CA078207, R01CA057436] Funding Source: NIH RePORTER
- NCI NIH HHS [R01CA57436, T32CA078207, R01CA81008] Funding Source: Medline
Phosphoinositide 3-kinase (PI3K) type IA is a heterodimer of a catalytic subunit, p110, and a regulatory subunit, p85. Here we show that p85 contains a GTPase-responsive domain and an inhibitory domain, which together form a molecular switch that regulates PI3K. H-Ras and Rac1 activate PI3K by targeting the GTPase-responsive domain. The stimulatory effect of these molecules, however, is blocked by the inhibitory domain, which functions by binding to tyrosine-phosphorylated molecules and is neutralized by tyrosine phosphorylation. The complementary effects of tyrosine kinases and small GTPases on the p85 molecular switch result in synergy between these two classes of molecules toward the activation of the PI3K/Akt pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据